Table 2 Semantic features of 139 cases of pGGOs diagnosed as MIA or precursor lesions.

From: Correlation between imaging features of pure ground-glass opacities and pathological subtypes of lung minimally invasive adenocarcinoma and precursor lesions

CT imaging signs

AAH / AIS (n = 80)

MIA (n = 59)

p

Shape

  

0.435

 Round

50 (62.50%)

33 (55.93%)

 

 Non-circular

30 (37.50%)

26 (44.07%)

 

Margins

  

0.536

 Clear

27 (33.75%)

17 (28.81%)

 

 Blurred

53 (66.25%)

42 (71.19%)

 

Spiculation

  

0.018

 Present

20 (25.00%)

26 (44.07%)

 

 Absent

60 (75.00%)

33 (55.93%)

 

Lobulation

  

0.086

 Present

7 (8.75%)

11 (18.64%)

 

 Absent

73 (91.25%)

48 (81.36%)

 

Vacuole sign

  

0.188

 Present

19 (23.75%)

20 (33.90%)

 

 Absent

61 (76.25%)

39 (66.10%)

 

Air bronchogram

  

0.081

 Present

5 (6.26%)

9 (15.25%)

 

 Absent

75 (93.75%)

50 (84.75%)

 

Pleural indentation

  

0.284

 Present

3 (3.75%)

5 (8.47%)

 

 Absent

77 (96.25%)

54 (91.53%)

 

Vascular convergence sign

  

0.525

 Present

27 (33.75%)

23 (38.98%)

 

 Absent

53 (66.25%)

36 (61.02%)

 

Pleural thickening

  

0.168

 Present

9 (11.25%)

2 (3.39%)

 

 Absent

71 (88.75%)

57 (96.61%)

 

Right lung

57 (71.25%)

37 (62.71%)

0.288

 Upper lobe

31 (38.75%)

15 (25.42%)

0.082

 Middle lobe

14 (17.50%)

5 (8.47%)

 

 Lower lobe

12 (15.00%)

17 (28.81%)

 

Left lung

23 (28.75%)

22 (37.29%)

 

 Upper lobe

15 (18.75%)

12 (20.34%)

 

 Lower lobe

8 (10.00%)

10 (16.95%)

 
  1. AAH, atypical adenomatous hyperplasia. AIS, adenocarcinoma in situ. MIA, minimally invasive adenocarcinoma. pGGO, pure ground-glass opacity.